94 related articles for article (PubMed ID: 10194621)
41. Cancer survival analysis in Hamburg 1995-2003: assessing the data quality within a population-based registry.
Nennecke AL; Hentschel S; Reintjes R
Acta Oncol; 2009; 48(1):34-43. PubMed ID: 18607873
[TBL] [Abstract][Full Text] [Related]
42. Substantial overestimation of standard errors of relative survival rates of cancer patients.
Brenner H; Hakulinen T
Am J Epidemiol; 2005 Apr; 161(8):781-6. PubMed ID: 15800271
[TBL] [Abstract][Full Text] [Related]
43. Model based hybrid analysis of cancer patient survival.
Brenner H; Hakulinen T
Eur J Cancer; 2007 Mar; 43(5):921-7. PubMed ID: 17329096
[TBL] [Abstract][Full Text] [Related]
44. Socioeconomic inequalities in cancer survival in New Zealand: the role of extent of disease at diagnosis.
Jeffreys M; Sarfati D; Stevanovic V; Tobias M; Lewis C; Pearce N; Blakely T
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):915-21. PubMed ID: 19223561
[TBL] [Abstract][Full Text] [Related]
45. Association of diabetes with survival among cohorts of Indigenous and non-Indigenous Australians with cancer.
Martin JH; Coory MD; Valery PC; Green AC
Cancer Causes Control; 2009 Apr; 20(3):355-60. PubMed ID: 18953694
[TBL] [Abstract][Full Text] [Related]
46. Period analysis of cancer patient survival in datasets from which the month of diagnosis has been removed.
Brenner H; Arndt V
Eur J Cancer; 2005 Feb; 41(3):438-44. PubMed ID: 15691645
[TBL] [Abstract][Full Text] [Related]
47. Prognostic factors in the diagnostic work-up of cancer patients in an internal medicine department: does age matter?
Domingo E; Suriñach JM; Murillo J; Duran M; Suriñach J; Baselga J; de Sevilla TF
Int J Clin Pract; 2008 Nov; 62(11):1723-9. PubMed ID: 19143858
[TBL] [Abstract][Full Text] [Related]
48. Up-to-date estimates of cancer patient survival even with common latency in cancer registration.
Brenner H; Hakulinen T
Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1727-32. PubMed ID: 16985036
[TBL] [Abstract][Full Text] [Related]
49. Methodologic issues in follow-up studies of cancer incidence among occupational groups in the United States.
Bender TJ; Beall C; Cheng H; Herrick RF; Kahn AR; Matthews R; Sathiakumar N; Schymura MJ; Stewart JH; Delzell E
Ann Epidemiol; 2006 Mar; 16(3):170-9. PubMed ID: 16181790
[TBL] [Abstract][Full Text] [Related]
50. Are patients diagnosed with breast cancer before age 50 years ever cured?
Brenner H; Hakulinen T
J Clin Oncol; 2004 Feb; 22(3):432-8. PubMed ID: 14691121
[TBL] [Abstract][Full Text] [Related]
51. Estimating life expectancy and related probabilities in screen-detected breast cancer patients with restricted follow-up information.
Straatman H; Verbeek AL; Peer PG; Borm G
Stat Med; 2004 Feb; 23(3):431-48. PubMed ID: 14748037
[TBL] [Abstract][Full Text] [Related]
52. Cancer statistics: everything you wanted to know about the cancer registry data but were too afraid to ask.
Giles GG; Thursfield V
ANZ J Surg; 2004 Nov; 74(11):931-4. PubMed ID: 15550077
[TBL] [Abstract][Full Text] [Related]
53. Basic issues in estimating and comparing the survival of cancer patients.
Berrino F; Estève J; Coleman MP
IARC Sci Publ; 1995; (132):1-14. PubMed ID: 7797291
[No Abstract] [Full Text] [Related]
54. Guidelines for evaluation of follow-up articles and preparation of mortality abstracts.
Singer RB; Kita MW
J Insur Med; 1991; 23(1):21-9. PubMed ID: 10148468
[No Abstract] [Full Text] [Related]
55. [Basic tasks of the statistical analysis of data on the survival of cancer patients].
Kadyrova NO; Antipova TV; Zherbin EA; Iakovlev AIu
Vopr Onkol; 1984; 30(7):24-32. PubMed ID: 6464399
[No Abstract] [Full Text] [Related]
56. The EUROCARE Study: strengths, limitations and perspectives of population-based, comparative survival studies.
Berrino F
Ann Oncol; 2003; 14 Suppl 5():v9-13. PubMed ID: 14684497
[No Abstract] [Full Text] [Related]
57. [Estimation of the statistical significance of survival rates in cancer patients].
Berezkin DP; Filatov VN
Vopr Onkol; 1985; 31(4):12-5. PubMed ID: 4002665
[No Abstract] [Full Text] [Related]
58. [Evaluation of the results of treating malignant neoplasms according to the indices of survival].
Shnitnikova ZZ
Vopr Onkol; 1974; 20(9):24-9. PubMed ID: 4428653
[No Abstract] [Full Text] [Related]
59. [An analysis of survival data in the epidemiological context].
Estève J
Gac Sanit; 1992; 6(29):78-85. PubMed ID: 1624235
[TBL] [Abstract][Full Text] [Related]
60. Median versus mean lifetime survival in the analysis of survival data.
Messori A; Becagli P; Trippoli S
Haematologica; 1997; 82(6):730. PubMed ID: 9499681
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
